How does CLV's PE Ratio compare to its peers?

CLV is expensive based on its Price-To-Earnings Ratio (53.5x) compared to the peer average (16x).

How does CLV's PE Ratio compare vs other companies in the Global Chemicals Industry?

CLV is expensive based on its Price-To-Earnings Ratio (53.5x) compared to the Global Chemicals industry average (21.7x).

What is CLV's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CLV is expensive based on its Price-To-Earnings Ratio (53.5x) compared to the estimated Fair Price-To-Earnings Ratio (20.7x).

What is the Fair Price of CLV when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

CLV (A$0.49) is trading below our estimate of [[fair value]] (A$1.66)

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

Clover (CHIA:CLV) - Stock Price, News & Analysis

CLV Stock Overview

Engages in the production, refining, and sale of natural oils and encapsulated powders in Australia, New Zealand, Asia, Europe, the Middle East, and the Americas. More details

CLV fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	4/6
Past Performance	1/6
Financial Health	6/6
Dividends	2/6

Rewards

Trading at 70.4% below our estimate of its fair value

Earnings are forecast to grow 35.74% per year

Risk Analysis

Profit margins (2.4%) are lower than last year (7.8%)

Does not have a meaningful market cap (A$81M)

Clover Corporation Limited Competitors

DGL Group

ASX:DGL

AU$155.4m

SciDev

ASX:SDV

AU$94.0m

Challenger Gold

ASX:CEL

AU$81.3m

Beacon Minerals

ASX:BCN

AU$82.6m

Price History & Performance

Summary of all time highs, changes and price drops for Clover
Historical stock prices
Current Share Price	AU$0.49
52 Week High	AU$0.90
52 Week Low	AU$0.36
Beta	0.36
11 Month Change	-3.92%
3 Month Change	8.29%
1 Year Change	-36.36%
33 Year Change	-70.83%
5 Year Change	-82.87%
Change since IPO	15.29%

Recent updates

Shareholder Returns

	CLV	AU Chemicals	AU Market
7D	-1.0%	3.5%	1.5%
1Y	-36.4%	6.2%	17.2%

Return vs Industry: CLV underperformed the Australian Chemicals industry which returned 6.2% over the past year.

Return vs Market: CLV underperformed the Australian Market which returned 17.2% over the past year.

Price Volatility

Is CLV's price volatile compared to industry and market?
CLV volatility
CLV Average Weekly Movement	10.9%
Chemicals Industry Average Movement	10.3%
Market Average Movement	8.6%
10% most volatile stocks in AU Market	17.3%
10% least volatile stocks in AU Market	3.4%

Stable Share Price: CLV has not had significant price volatility in the past 3 months compared to the Australian market.

Volatility Over Time: CLV's weekly volatility (11%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
1988	60	Peter Davey	www.clovercorp.com.au

Clover Corporation Limited engages in the production, refining, and sale of natural oils and encapsulated powders in Australia, New Zealand, Asia, Europe, the Middle East, and the Americas. It supplies refined Omega 3 oils and various encapsulated ingredients for use in infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. The company offers Nu-Mega’s Driphorm, a microencapsulated powders with the addition of Hi-DHA tuna and/or algal oils.

Clover Corporation Limited Fundamentals Summary

How do Clover's earnings and revenue compare to its market cap?
CLV fundamental statistics
Market cap	AU$80.99m
Earnings (TTM)	AU$1.52m
Revenue (TTM)	AU$62.21m

53.5x

P/E Ratio

1.3x

P/S Ratio

Is CLV overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CLV income statement (TTM)
Revenue	AU$62.21m
Cost of Revenue	AU$45.35m
Gross Profit	AU$16.86m
Other Expenses	AU$15.35m
Earnings	AU$1.52m

Last Reported Earnings

Jul 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	0.0091
Gross Margin	27.11%
Net Profit Margin	2.44%
Debt/Equity Ratio	12.6%

How did CLV perform over the long term?

See historical performance and comparison

Dividends

1.5%

Current Dividend Yield

83%

Payout Ratio

CLV Stock Overview

Rewards

Risk Analysis

Clover Corporation Limited Competitors

ASX:DGL

AU$155.4m

ASX:SDV

AU$94.0m

ASX:CEL

AU$81.3m

ASX:BCN

AU$82.6m

Price History & Performance

Recent News & Updates

Dividend of AU$0.0075 announced

Full year 2024 earnings released: EPS: AU$0.009 (vs AU$0.037 in FY 2023)

New major risk - Revenue and earnings growth

Now 22% undervalued after recent price drop

Now 20% undervalued after recent price drop

Now 21% undervalued after recent price drop

Recent updates

Dividend of AU$0.0075 announced

Full year 2024 earnings released: EPS: AU$0.009 (vs AU$0.037 in FY 2023)

New major risk - Revenue and earnings growth

Now 22% undervalued after recent price drop

Now 20% undervalued after recent price drop

Now 21% undervalued after recent price drop

Independent Non-Executive Chairman recently bought AU$100k worth of stock

Now 23% undervalued after recent price drop

First half 2024 earnings released: AU$0.004 loss per share (vs AU$0.022 profit in 1H 2023)

Clover Corporation Limited Declares Payment of Final Dividend for the Financial Year 2023

Insufficient new directors

Clover Corporation Limited, Annual General Meeting, Nov 23, 2023

New minor risk - Market cap size

Full year 2023 earnings released: EPS: AU$0.037 (vs AU$0.043 in FY 2022)

Clover Corporation Limited Declares Fully Franked Final Dividend for the Financial Year Ended 31 July 2023, Payable on 20 November 2023

First half 2023 earnings released: EPS: AU$0.022 (vs AU$0.012 in 1H 2022)

Clover Corporation Limited Payment of Final Dividend for the Financial Year 2022

Clover Informs Study Results by the South Australian Health and Medical Research Institute

Clover Corporation Limited Declares Fully Franked Final Dividend for the Year Ended 31 July 2022, Payable on 22 November 2022

Upcoming dividend of AU$0.01 per share

Clover Corporation Limited, Annual General Meeting, Nov 24, 2022

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

First half 2022 earnings: EPS in line with expectations, revenues disappoint

Now 23% undervalued after recent price drop

Full year 2021 earnings released: EPS AU$0.036 (vs AU$0.075 in FY 2020)

Investor sentiment improved over the past week

CFO & Company Secretary has left the company

Investor sentiment deteriorated over the past week

Clover Corporation Ltd Announces Payment of Interim Dividend for the Half Year Ended January 31, 2021

Investor sentiment improved over the past week

First half 2021 earnings released: EPS AU$0.015 (vs AU$0.028 in 1H 2020)

Clover Corporation Limited Provides Revenue Guidance for the Fiscal Year 2021

Clover Corporation Limited Declares Dividend for the First Half of 2021, Payable on April 29, 2021

New 90-day low: AU$1.45

New 90-day low: AU$1.47

New 90-day low: AU$1.62

CEO, MD & Director recently sold AU$404k worth of stock

Independent Chairman recently bought AU$99k worth of stock

Clover Corporation Limited Announces Board Changes

New 90-day low: AU$2.00

New 90-day low: AU$2.10

Full year earnings released

New 90-day high - AU$2.40

Shareholder Returns

Price Volatility

About the Company

Clover Corporation Limited Fundamentals Summary

53.5x

1.3x

Earnings & Revenue

Dividends

1.5%

83%